Effect of Tegaserod on Gastric Emptying in Patients With Diabetic Gastroparesis

NCT00390975 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

40

Enrollment

INDUSTRY

Sponsor class

Stopped This study was terminated early as a result of regulatory action suspending tegaserod use in 2007

Conditions

Gastroparesis
Diabetes

Interventions

DRUG: Tegaserod

Sponsor

Novartis